Ways to overcome resistance to antihypertensive therapy in hypertensive patients: role of doxazosin

by I. V. Emelyanov, A. O. Conradi
Published 2014-12-01

COMPARATIVE RESEARCH OF ENALAPRIL AND ATENOLOL ANTIHYPERTENSIVE EFFICACY IN HIGH RISK PATIENTS

by O. M. Moiseeva, S. V. Villevalde, I. V. Emelyanov, T. G. Ivanova
Published 2016-01-01

Enalapril therapy and thrombotic or inflammatory disturbances in essential arterial hypertension

by O. M. Moiseeva, O. A. Berkovich, S. V. Villevalde, I. V. Emelyanov
Published 2005-08-01

Enalapril therapy and thrombotic and inflammatory abnormalities in essential arterial hypertension

by O. M. Moiseeva, O. A. Berkovich, S. V. Villevalde, I. V. Emelyanov
Published 2005-12-01

The role of beta-blockers in the treatment of hypertension in 2018 ESC/ESH guidelines

by A. O. Konradi, L. G. Ratova, I. V. Emelyanov, A. O. Nedoshivin
Published 2018-12-01

FUNCTIONAL STATE DYNAMICS OF BLOOD CELLS AND ENDOTHELIUM IN PATIENTS WITH ESSENTIAL HYPERTENSION WITH ENALAPRIL TREATMENT

by O. M. Moisseyeva, O. A. Berkovich, S. V. Villevalde, E. A. Lyasnikova, I. V. Emelyanov
Published 2003-12-01

Association of the increased circulating CD62LloCXCR4hi neutrophil count with carotid atherosclerosis

by I. I. Dolgushin, V. V. Genkel, I. L. Baturina, I. V. Emelyanov, A. Y. Savochkina, I. I. Shaposhnik
Published 2021-05-01

Immediate and Long-term Results of Stenting of the Unprotected Left Coronary Artery Trunk in Patients with Stable Coronary Heart Disease

by G. K. Arutyunyan, S. I. Provatorov, N. S. Zhukova, A. S. Tereshchenko, D. V. Ognerubov, I. V. Emel’yanov, I. V. Krasnoshchekov, A. N. Samko
Published 2019-05-01

Novel biomarkers of kidney injury and fibrosis in patients with different severity of hypertension: relation to vascular reactivity and stiffness

by S. A. Mironova, Yu. S. Yudina, M. A. Ionov, N. G. Avdonina, I. V. Emelyanov, E. Yu. Vasil`eva, E. A. Kitaeva, N. E. Zvartau, A. O. Konradi
Published 2019-02-01